Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Nov 03, 2015 8:14pm

107 Views

Post# 24255667

RE:Dr. Frost's prostate cancer strategy ...

Bencro,

Didn't you give everyone here an update on Jack Frost 1 year ago, then 9 months ago then 6.months ago then 3 months ago. I mean, is there anyone here who hasn't heard of Jack Frost?

Now if you could just inform the shareholders of when the ph1 HC trials will start (oh yeah, this time last year it was a ph1/2a with FDA and HC... Anyone still remember that) or when the TLC2000 approval will come, then that would be useful info.

Thanks good buddy! Can't wait for your next expose on "2015, the year of light".

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row